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Abstract
Aims/hypothesis Impaired awareness of hypoglycaemia (IAH) in type 1 diabetes increases the risk of severe hypoglycaemia
sixfold and can be resistant to intervention. We explored the impact of IAH on central responses to hypoglycaemia to investigate
the mechanisms underlying barriers to therapeutic intervention.
Methods We conducted [15O]water positron emission tomography studies of regional brain perfusion during euglycaemia (target
5 mmol/l), hypoglycaemia (achieved level, 2.4 mmol/l) and recovery (target 5 mmol/l) in 17 men with type 1 diabetes: eight with
IAH, and nine with intact hypoglycaemia awareness (HA).
Results Hypoglycaemia with HAwas associated with increased activation in brain regions including the thalamus, insula, globus
pallidus (GP), anterior cingulate cortex (ACC), orbital cortex, dorsolateral frontal (DLF) cortex, angular gyrus and amygdala;
deactivation occurred in the temporal and parahippocampal regions. IAHwas associated with reduced catecholamine and symptom
responses to hypoglycaemia vs HA (incremental AUC: autonomic scores, 26.2 ± 35.5 vs 422.7 ± 237.1; neuroglycopenic scores,
34.8 ± 88.8 vs 478.9 ± 311.1; both p < 0.002). There were subtle differences (p < 0.005, k ≥ 50 voxels) in brain activation at
hypoglycaemia, including early differences in the right central operculum, bilateral medial orbital (MO) cortex, and left posterior
DLF cortex, with additional differences in the ACC, right GP and post- and pre-central gyri in established hypoglycaemia, and lack
of deactivation in temporal regions in established hypoglycaemia.
Conclusions/interpretation Differences in activation in the post- and pre-central gyri may be expected in people with reduced
subjective responses to hypoglycaemia. Alterations in the activity of regions involved in the drive to eat (operculum), emotional
salience (MO cortex), aversion (GP) and recall (temporal) suggest differences in the perceived importance and urgency of
responses to hypoglycaemia in IAH compared with HA, which may be key to the persistence of the condition.
Keywords Counterregulation . Hypoglycaemia . Impaired awareness of hypoglycaemia . Neuroimaging . Positron emission
tomography . Type 1 diabetes
Abbreviations
ACC Anterior cingulate cortex
CT Computerised tomography
DLF Dorsolateral frontal
fMRI Functional MRI
GP Globus pallidus
HA Hypoglycaemia awareness
IAH Impaired awareness of hypoglycaemia
iAUC Incremental AUC
k Cluster size
MO Medial orbital
PET Positron emission tomography
rCBF Regional cerebral blood flow
SPM Statistical Parametric Mapping 2
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Introduction
For people with diabetes, the main defence against severe
hypoglycaemia, in which blood glucose falls too low to sus-
tain cognitive function [1], is subjective awareness of minor
episodes. Impaired awareness of hypoglycaemia (IAH) is as-
sociated with delayed and diminished counterregulatory re-
sponses to hypoglycaemia [2]. It is reported in 25–40% of
people with longstanding type 1 diabetes mellitus [3, 4], and
10%with insulin-treated type 2 diabetes [5], increasing risk of
severe hypoglycaemia 6- and 17-fold respectively [3–5].
The brain triggers counterregulatory neuroendocrine re-
sponses to hypoglycaemia, symptom perception, and coordi-
nation of endogenous and behavioural protective responses.
Animal studies [6] have hypothesised that IAH, which is in-
ducible by exposure to plasma glucose below 3 mmol/l [7, 8],
is associated with increased brain capacity for glucose uptake.
However, early studies of enhanced global brain glucose up-
take in humans [9] are not compatible with the clinical picture
of IAH, where deterioration of cognitive function precedes the
onset of diminished and asymptomatic counterregulatory re-
sponses [10]. Early neuroimaging studies failed to confirm a
global increase in glucose uptake in IAH [11].
Functional neuroimaging investigates the brain’s response
to a challenge by measuring regional changes in glucose up-
take and metabolism or perfusion as markers of neuronal ac-
tivation. Activation of the hypothalamus, important in glucose
sensing, has been described with modest decrements of blood
glucose (to 4.3 mmol/l) in healthy volunteers [12]. More
extensive activation, including the dorsal-medial thalamus,
globus pallidus (GP) and anterior cingulate cortex (ACC),
has been described in healthy people at 3 mmol/l and consid-
ered to be associated with autonomic stress responses [13].
Using [15O]water positron emission tomography (PET) scans
repeated during induction of, maintenance of and recovery
from hypoglycaemia at 2.8 mmol/l, we described activation
of the thalamus and ACC, with progressive involvement of
pathways involved in feeding behaviour and reward, symp-
tom perception and aversion [14].
Less is known about the impact of diabetes and
hypoglycaemia awareness (HA) status. Hormone responses
to hypoglycaemia are diminished in type 1 diabetes [15], but
the importance for symptoms experienced is unclear [16].
Thalamic activation has been described as enhanced in a mod-
el of IAH [17] but reduced in IAH itself [18]. A recent study
compared a single measurement of global and regional cere-
bral blood flow (rCBF) after 45 min at 2.8 mmol/l in people
with type 1 diabetes with and without IAH using arterial spin-
labelling MRI. This reported a global increase in cerebral
blood flow only in IAH, and failure of an enhanced regional
thalamic response [19], but there are no reports of IAH-
specific differences in other regional responses.
Understanding the central pathophysiology of IAH is key
to its management. Although IAH can be restored by avoiding
hypoglycaemia [2, 20], this can be difficult to achieve, with
8% of adults with type 1 diabetes showing low concern about
hypoglycaemia despite being at high risk [21]. Cognitions
around hypoglycaemia may create barriers to its avoidance
•
•
•
•
•
•
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[22]. We therefore extended the use of repeated [15O]water
PET scans to measure changes in regional brain perfusion
during sequential euglycaemia, hypoglycaemia and recovery
in men with type 1 diabetes with and without IAH.
Methods
Participants
Right-handed men with type 1 diabetes aged between 20 and
50 years, with HbA1c levels less than 86 mmol/mol (<10%),
were recruited into two groups, based on their awareness of
hypoglycaemia as defined by history and 8-item Clarke score
[23]. HA was defined as good awareness of occasional
hypoglycaemia, no severe hypoglycaemia in the past year
and a Clarke score ≤3. IAH was defined by history, including
experience of severe hypoglycaemia, and Clarke score ≥4.
The protocol was approved by the Ethics Committee of
King’s College Hospital London and the Administration of
Radioactive Substances Committee (ARSCAC, Health
Protection Agency, Didcot, Oxfordshire, UK). All participants
gave written informed consent.
Protocol
Scans were performed at the PET Imaging Centre, St Thomas’
Hospital, London, using a GE Discovery ST PET/
computerised tomography (CT) scanner (GE Medical
Systems, Milwaukee, WI, USA) with a 15.8 cm axial field
of view. Participants were admitted the evening before the
study. Two intravenous cannulae were inserted for infusion
of soluble insulin (Actrapid; NovoNordisk, Copenhagen,
Denmark) in a 4% (vol./vol.) saline (154 mmol/l NaCl) solu-
tion of autologous blood; blood was sampled hourly.
Participants fasted after their eveningmeal, sips of water being
allowed, and omitted their evening background insulin dose.
To achieve normoglycaemia without hypoglycaemia, plasma
glucose was maintained between 4 and 7 mmol/l overnight by
adjusting the insulin infusion.
In the morning, the left radial artery was cannulated. After
at least 20 min, each participant rested supine on the scanner
trolley, in a headrest with a forehead positioning strap. Once in
the scanner, the head position was checked using gantry la-
sers. A new primed-continuous infusion of soluble insulin was
started, at a maintenance rate 1.5 mU kg−1 min−1. Four mi-
nutes later, an infusion of 10% (wt/vol.) glucose (Baxter
Healthcare, Thetford, Norfolk, UK) was started and was ad-
justed using 5 min arterial plasma glucose readings (YSI 2300
Stat Plus; Yellow Springs Instruments, Yellow Springs, OH,
USA). The target plasma glucose level was 5 mmol/l for
40 min, with a reduction over 20 min to 2.6 mmol/l, mainte-
nance at 2.6 mmol/l for 45 min, and restoration to 5 mmol/l
(over 15–20 min) for 30 min. The insulin was then stopped,
and the participant withdrawn from the scanner. He was then
given lunch, with his usual subcutaneous fast-acting insulin
pre-meal dose and, if a morning dose of basal insulin had been
omitted, a reduced basal insulin dose to provide cover until the
evening dose. The glucose infusion was reduced and plasma
glucose monitored until concentrations were spontaneously
maintained. The cannulae were then removed. Participants
were advised about monitoring and dosing to minimise risk
of hypoglycaemia over the next 24 h.
Scanning protocol
This was as previously reported [14]. In brief, the brain was
localised in the PET view field using a planar CT scout. A
low-dose CT scan was acquired to correct attenuation in sub-
sequent PET scans. Head position was checked, and 3 min [15
O]water PET scans were made at 10 min intervals. For each
scan, 350 MBq [15O]water in 10 ml sterile water was manu-
ally injected intravenously over 10 s. Three scans were ac-
quired during euglycaemia: one during the fall in glucose, five
during the hypoglycaemic phase and three during recovery.
Scans were acquired in 3D mode, reconstructed to a single
static frame using the 3D FORE algorithm [24], and 2D-
filtered back-projection with scatter correction and CT-based
correction of attenuation. To minimise movement artefacts,
each participant’s CT scan was realigned to each PET scan
using the rigid-body registration algorithm in the Statistical
Parametric Mapping 2 program (SPM2; www.fil.ion.ucl.ac.
uk/spm, accessed 15 March 2013). The realigned CT was
used to correct the attenuation in the PET reconstruction.
Assessment of physiological responses
After scanning, arterial blood was taken to measure
counterregulatory hormones. The participant was asked ver-
bally to rate (from 1 to 7) 13 hypoglycaemia-associated symp-
toms (see below) [25].
Biochemical analyses
Blood was kept on ice, spun, separated and flash-frozen on
dry ice until storage. Avolume of 1 ml was added to 30% (wt/
vol.) polyethylene glycol for free insulin radioimmunoassay
(Diagnostic Systems Laboratories, London, UK). Blood
(3 ml) for catecholamines was taken into heparinised tubes
containing 15 μl sodium metabisulphite; plasma was separat-
ed at the time of study, stored at −80°C and analysed by
radioimmunoassay [14].
Symptom scores Scores for sweating, shakiness, anxiety,
warmth, palpitation and tingling were summed as autonomic.
Scores for dizziness, irritability, difficulty in speaking,
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confusion, lack of energy, drowsiness and poor concentration
were totalled as neuroglycopenic.
Statistical analyses of non-imaging data
Age, BMI, HbA1c and duration of diabetes were com-
pared between groups using independent sample t tests,
and Clarke scores by Mann–Whitney U testing. Hormonal
and symptom responses to hypoglycaemia and impact of
awareness status were examined by calculating the main
and interaction effects of scan and group on each variable
using a repeated measures linear mixed model (first-order
autoregressive covariance structure). To assess the effect
of hypoglycaemia, baseline values for each variable were
calculated by averaging data from scans 1–3. A summary
statistic of response to the total hypoglycaemic period was
calculated as the incremental AUC (iAUC) of the re-
sponse in scans 4–9. The effect of hypoglycaemia was
tested using a one-sample t test of the iAUC if the mixed
model revealed significant scan or interaction effects. To
assess differences between the two groups, the baseline
and iAUC measures were used in two-sample t tests if
the mixed model revealed significant group or interaction
effects. Analyses were performed using SPSS software
version 24 (www-01.ibm.com/software/uk/analytics/
spss/).
Neuroimaging analysis
The analytic program was chosen to allow interrogation of
the data without preconceptions of the brain regions that
might respond to hypoglycaemia in people with type 1
diabetes or respond differently between HA and IAH.
SPM2 was used to preprocess and analyse the PET data.
Image processing and analysis of regional perfusion were
performed automatically and identically in each partici-
pant or group, removing the need for blinding. PET im-
ages were transformed into standard anatomical space
conforming to the standard Montreal Neurological
Institute (MNI) space using the [15O]water PET template
supplied with SPM2, masked to exclude the scalp and
smoothed using a Gaussian kernel (full width at half max-
imum [FWHM] = 6 mm).
Within SPM2, each image was spatially normalised to its
whole-brain mean using SPM2, which performs an initial af-
fine registration followed by a basis function method non-
linear registration [26] and calculates regional perfusion rela-
tive to the whole-brain mean. SPM2 calculates the mean im-
age intensity across the whole brain, without segmentation,
using its default threshold method (mean of the overall mean ×
0.8), and uses integrated activity over time (here 3 min),
which is proportional to rCBF [27].
For analysis, scans were grouped as: euglycaemia/baseline
(scans 1–3), early hypoglycaemia (scans 4–6), established
hypoglycaemia (scans 7–9) and recovery (scans 10–12).
Two-way repeated measures ANOVAwas used to investigate
the main effects of stage of hypoglycaemia (early, late or re-
covery vs baseline), group and interactions [28].
Regions of significant effects were calculated using a
voxel-level p value <0.001 and cluster sizes (k) ≥100
voxels; these were recalculated at p < 0.005, k ≥ 50 voxels
to examine for smaller differences where more significant
differences had been excluded. t values <2 (or <−2) indi-
cate significance with >95% confidence. Clusters were
localised using the Tziortzi atlas [29].
Results
Participants
Of the 17 men with type 1 diabetes recruited, nine had
intact HA. These nine individuals were aged 37.6 ±
9.3 years and had a diabetes duration of 14.3 ± 12.3 years,
BMI, 23.4 ± 3.4 kg/m2 and HbA1c, 58.5 ± 12.4 mmol/mol
(7.5 ± 1.3%) (all means ± SD). They reported good aware-
ness of hypoglycaemia, with a median Clarke score of 2
(range 1–3) and no severe hypoglycaemia in the past year.
The other eight men (means ± SD: age, 36.4 ± 7.8 years;
diabetes duration, 27.1 ± 11.9 years; BMI, 26.6 ± 1.4 kg/
m2; HbA1c, 57.7 ± 9.3 mmol/mol [7.3 ± 0.8%]) had IAH,
with a median Clarke score of 5.5 (range 4–6); all had a
history of severe hypoglycaemia. The IAH and HA
groups did not differ in terms of age (p = 0.79), duration
of diabetes (p = 0.07) or HbA1c (p = 0.89) but had slight-
ly a greater BMI (p = 0.02). By design, Clarke scores
were significantly different between groups (p < 0.001).
Plasma insulin, glucose, symptoms
and counterregulatory hormones
During the studies, steady-state free plasma insulin was
(mean ± SD) 476.4 ± 138.48 and 487.9 ± 225.3 pmol/l
for the HA and IAH group, respectively (p = 0.89).
The hypoglycaemia achieved (Fig. 1a) did not differ
between groups (2.4 ± 0.1 and 2.4 ± 0.1 mmol/l, respec-
tively; p = 0.7); there were no significant differences in
starting glucose level, or glucose concentration during
recovery. Mean glucose levels were: scan 4, 3.4 ± 0.2
vs 3.5 ± 0.4; scan 5, 2.7 ± 0.2 vs 2.7 ± 0.3; and scan 6
2.2 ± 0.3 vs 2.3 ± 0.2 (all p > 0.05). Hormone concentra-
tions did not differ between the groups during
euglycaemia. Adrenaline (epinephrine) and noradrenaline
(norepinephrine) (Fig. 1b, c) showed significant main
e f f e c t s o f s can numbe r ( s e e a l s o e l e c t r on i c
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supplementary material [ESM] Table 1), with a signifi-
cant interaction effect of scan and group for adrenaline
levels. Post hoc tests of effect of hypoglycaemia using iAUC
revealed significant responses in HA for adrenaline (p < 0.001)
and noradrenaline (p = 0.009). The adrenaline response with
IAH was significant (p = 0.003) but significantly lower than
for HA (p for comparison = 0.007). There was a significant
noradrenaline response only in the HA group (p = 0.009). The
iAUC for cortisol did not reach significance in either group,
with a trend towards significance for HA (p = 0.075; see
ESM Table 1). The iAUC for growth hormone was significant
in both groups (HA, p = 0.035; IAH, p = 0.006; see ESM
Table 1).
Symptom responses
Significant main effects for scan, group and interaction were
revealed in autonomic and neuroglycopenic total scores (Fig.
1d, e; ESM Table 1). The HA group showed significant re-
sponses (iAUC) for both scores (422.7 ± 237.1, p = 0.001 and
478.9 ± 311.1, p = 0.002, respectively). The IAH group
showed a small response for autonomic scores (26.2 ± 35.5;
p = 0.038), significantly lower than the response with HA
(p = 0.002), and no significant neuroglycopenic symptom re-
sponse (34.8 ± 88.8, p = 0.15 from baseline, p = 0.002 vs HA
group). Baseline autonomic scores were slightly higher for
HA than IAH (p = 0.024), with a mean difference in score
of 1.5, which was small in comparison with the mean increase
of 10.5 seen during hypoglycaemia.
Neuroimaging data
Regional brain responses to acute hypoglycaemia in type 1
diabetes with preserved HA The response to early
hypoglycaemia across HA participants (Fig. 2a, ESM
Table 2) included a regional increase in perfusion (compared
with baseline) in the thalamic pulvinar bilaterally, bilateral dor-
solateral frontal (DLF) cortices, right insular cortex and ACC;
a decrease in perfusion was seen in the left inferior temporal
gyrus. As hypoglycaemia progressed (Fig. 2b, ESM Table 3),
the activation area became more extensive, with additional
activation (vs baseline) in the following: posterior, middle
and anterior thalamus and GP; bilateral insula and frontal oper-
cula; frontal cortex including the DLF cortex bilaterally and
lateral orbital cortex; ACC; and precuneus and right angular
gyrus/supramarginal gyrus/superior temporal gyrus. Perfusion
was reduced in established hypoglycaemia bilaterally in the
parahippocampal and posterior parietal cortex, inferior tempo-
ral gyri and parts of the cerebellum including the vermis.
During recovery (Fig. 2c, ESM Table 4), regions including
the ACC, GP, right insula and left precuneus showed activa-
tion; there was persisting deactivation in the inferior temporal
and posterior parietal gyri, and new activation of the amygdala.
Impact of awareness of hypoglycaemia on regional brain re-
sponses to hypoglycaemia Regional brain responses to
hypoglycaemia in IAH involved various regions similar to
those showing responses in the HA group (Fig. 2, ESM
Tables 5–7), with some differences that were explored in a
formal comparison. Directly comparing responses between
groups identified clusters showing significantly different
hypoglycaemia responses between the IAH and HA groups
at the second statistical threshold voxel level (p < 0.005, k ≥ 50
voxels) (Fig. 3; Table 1). In early hypoglycaemia (Fig. 3a–c),
five clusters were identified. One in the left lingual gyrus
showed deactivation for IAH and activation for HA, and
four—the right central operculum, medial orbital (MO) cortex
-20 0 20 40 60 80 100 120 140
Time from scan 1 (min)
1
2
3
4
5
6
P
la
sm
a 
gl
uc
os
e 
(m
m
ol
/l)
a
1 2 3 4 5 6 7 8 9 101112
Scan number
0
2
4
6
A
dr
en
al
in
e 
(n
m
ol
/l)
b
1 2 3 4 5 6 7 8 9 101112
Scan number
0
1
2
3
N
or
ad
re
na
lin
e 
(n
m
ol
/l)
c
1 2 3 4 5 6 7 8 9 101112
Scan number
0
10
20
30
A
ut
on
om
ic
 s
co
re
d
1 2 3 4 5 6 7 8 9 101112
Scan number
0
10
20
30
40
N
eu
ro
gl
yc
op
en
ic
 s
co
re
e
Fig. 1 Plasma glucose, catecholamine and symptom responses. Blue
lines, HA; red lines, IAH. (a) Plasma glucose levels (mean ± SD). Grey
bars represent scan time points. iAUC was not significantly different
between groups. (b, c) Mean ± SD at each scan for (b) plasma adrenaline
(iAUC, p = 0.007 between groups) and (c) plasma noradrenaline (signif-
icant response to hypoglycaemia in HA only (p < 0.009); no significant
difference in iAUC between groups. (d, e) Box plots showing median
(circles), upper and lower quartiles (box), range (vertical lines) and out-
liers (crosses) for (d) autonomic symptom scores and (e) neuroglycopenic
symptom scores. For both (d) and (e), difference between groups,
p = 0.002
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bilaterally and left posterior DLF cortex (two clusters)—
showed activation in IAH vs deactivation in HA.
As hypoglycaemia continued (Fig. 3d–f), eight clusters
showed significantly different changes in activation between
groups. Five showed limited or absent responses for IAH but
activation for HA: the right GP, ACC, dorsal cingulate cortex,
right pre- and bilateral post-central gyri, and left precuneus.
Two further clusters, in the right MO and left parietal cortices
(parietal lobule and angular gyrus), showed activation in IAH
but no change or deactivation in HA. A cluster including the
left posterior middle temporal gyrus, angular gyrus and occip-
ital pole showed no change in IAH but deactivation in HA.
Fourteen clusters showed significantly different activation be-
tween groups during the recovery period (Fig. 3g–i). IAH
showed deactivation or minimal response compared with acti-
vation in the HA group in the following: right fusiform cortex;
a midbrain cluster, extending to the right amygdala; right su-
perior temporal gyrus/insula; left pre- and post-central gyri;
and a cluster including right white matter, anterior temporal
pole and amygdala. The IAH group failed to show the deacti-
vation seen with HA in the bilateral middle and left inferior
temporal gyri. However, there was activation in IAH compared
with deactivation in HA in the left posterior medial frontal
cortex, left posterior DLF cortex extending to pre-central gy-
rus, and left angular gyrus/occipital pole/parietal lobule/
supramarginal gyrus/left posterior superior temporal gyrus.
Discussion
In this neuroimaging study of men with type 1 diabetes, dif-
ferences in symptomatic and hormonal responses to
hypoglycaemia between participants with preserved (HA) or
impaired (IAH) awareness of hypoglycaemia were accompa-
nied by subtle differences in brain responses. These occurred
not only in regions associated with the generation and subjec-
tive awareness of stress responses, but also in regions associ-
ated with executive control, reward, memory and emotional
salience.
Defective hormonal responses to hypoglycaemia in IAH
are well recognised [2, 8, 16]. They are inducible by exposure
to hypoglycaemia [7, 8] and restored by avoiding it [2, 20].
The IAH group showed the expected diminution of symptom-
atic and catecholamine responses to our hypoglycaemic
challenge.
Responses in men with type 1 diabetes and intact
awareness
Our neuroimaging data in HA participants are largely consis-
tent with studies in people without diabetes and extend earlier
observations, particularly by describing the evolution of re-
sponses during development of and recovery from
hypoglycaemia. Our ‘early’ scans were made as arterialised
plasma glucose level was falling, and include data collected at
glucose values between 3.5 and 2.2 mmol/l; the ‘established’
data were collected at 2.4 mmol/l. Thalamic activation seen in
both early and established hypoglycaemia is consistent with
data from individuals without diabetes, and with the role of the
thalamus in relaying sensory signals to cortical areas [30].
Novel findings include insula activation, seen in all three
phases of hypoglycaemia and not previously described in di-
abetes. Using similar techniques, we previously described in-
sular activation in established hypoglycaemia only in people
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without diabetes [14]; we speculate that earlier and more per-
sistent activation in type 1 diabetes relates to heightened
sensitivity to changes in plasma glucose or prior experience
of more fluctuating glucose concentrations. Wiegers et al did
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response is more positive for HA than IAH in early (b), established (e)
and recovered (h) hypoglycaemia. (c, f, i) Data for clusters where re-
sponse is more negative for HA than IAH in early (c), established (f)
and recovered (i) hypoglycaemia. Black bars, HA; white bars, IAH. a,
anterior; AG, angular gyrus; CC, cingulate cortex; CO, central opercu-
lum; d, dorsal; i, inferior; L, left; LG, lingual gyrus; m, medial;MF, medial
frontal cortex; MidB, midbrain; p, posterior; Par, parahippocampal gyrus;
PoCG, postcentral gyrus; PrCG, precentral gyrus; R, right; s, superior;
SMG, supramarginal gyrus; TG, temporal gyrus; TOF, temporal occipital
fusiform gyrus; TP, temporal gyrus. Where no laterality is noted (L or R),
the cluster was represented bilaterally. Where there are two data sets for
one brain region, there were two clusters in that region
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Table 1 Regions of the brain with different activation responses to hypoglycaemia in men with type 1 diabetes with HA vs those with IAH
Period vs baseline,
response direction
Group (region name) k (voxels) t (peak voxel) p(peak voxel) p(uncorrected
cluster)
Atlas coordinates for
location in the brain
Subcluster size
x y z
Early
HA > IAH Lingual gyrus L 54 3.57 0.00024 0.060 0 −74 −6 31
Lingual gyrus R 23
HA < IAH Post dorsolateral
frontal cortex L
79 −3.47 0.00034 0.026 −48 22 12 79
Post dorsolateral
frontal cortex L
54 −4.40 0.00001 0.060 −32 26 46 54
Insular cortex Ra 55 −3.53 0.00027 0.058 44 −2 10 4
Precentral gyrus Ra 3
Central operculum cortex R 44
Cerebral white matter Ra 4
Medial orbital cortex La 70 −4.17 0.00003 0.035 4 62 −14 11
Medial orbital cortex R 59
Established
HA > IAH Precentral gyrus La 128 3.84 0.00009 0.007 −6 −38 66 9
Postcentral gyrus L 95
Cerebral white matter Ra 30
Precentral gyrus R 89 4.01 0.00005 0.020 20 −28 66 56
Postcentral gyrus R 33
Dorsal ant cingulate cortex 42
Cerebral white matter Ra 8
Ant cingulate cortex 68 4.03 0.00004 0.037 −2 36 6 68
HA < IAH Parietal lobule L 109 −4.75 <0.00001 0.011 −34 −58 40 54
Supramarginal gyrus La 2
Angular gyrus L 53
Middle temp gyrus post L 171 −4.18 0.00002 0.002 −54 −62 16 76
Angular gyrus L 63
Occipital pole L 32
Medial orbital cortex La 133 −3.76 0.00012 0.006 4 60 −12 6
Medial orbital cortex R 127
Recovery
HA > IAH Outside atlasa 127 3.53 0.00027 0.007 40 −40 −16 4
Inf temp gyrus post Ra 1
Cerebral white matter Ra 7
Postcentral gyrus L 58
Outside atlasa 111 3.79 0.00011 0.010 10 −8 −16 23
Cerebral white matter Ra 17
Hippocampus Ra 9
Amygdala R 22
Midbrain 30
Precentral gyrus L 119 3.84 0.00009 0.008 −38 −24 62 25
Postcentral gyrus L 94
Insular cortex R 78 3.42 0.0004 0.027 42 −22 0 11
Sup temp gyrus ant R 52
Sup temp gyrus post Ra 7
Cerebral white matter Ra 8
Outside atlasa 79 3.81 0.0001 0.026 32 2 −20 3
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not find insular activation in people without diabetes and de-
scribed reduced insular perfusion using functional MRI
(fMRI) in seven HA individuals with type 1 diabetes [19].
Comparing direction of signal change across studies using
different technologies is complex; however, [15O]water PET
is less susceptible to low signal to noise ratios and movement
than fMRI. It also allows more quantitative measurement of
regional responses and may be better at detecting differences
between groups in studies of similar size [31].
Activation of the GP in established hypoglycaemia and
recovery, and the ACC in all three phases, is consistent with
some reports involving individuals without diabetes at similar
glucose concentrations [13, 14] but has not been described in
type 1 diabetes. The GP and ACC, involved in reward, might
Table 1 (continued)
Period vs baseline,
response direction
Group (region name) k (voxels) t (peak voxel) p(peak voxel) p(uncorrected
cluster)
Atlas coordinates for
location in the brain
Subcluster size
x y z
Insular cortex Ra 10
Ant temp pole R 21
Parahippocampal
ambiens gyrus ant Ra
1
Cerebral white matter R 27
Amygdala R 17
HA < IAH Middle temp gyrus ant L 97 −5.02 <0.00001 0.015 −64 −14 −14 32
Middle temp gyrus post L 56
Inf temp gyrus ant La 3
Inf temp gyrus post La 6
Sup temp gyrus post L 138 −4.56 <0.00001 0.005 −58 −48 16 43
Middle temp gyrus post La 1
Supramarginal gyrus L 68
Angular gyrus L 23
Cerebral white matter La 3
Ant dorsolateral
frontal cortex La
78 −4.42 <0.00001 0.027 −10 50 34 10
Anterior medial
frontal cortex La
6
Postero-medial
frontal cortex L
62
Middle temp gyrus post L 90 −4.01 0.00005 0.019 −56 −34 −22 22
Inf temp gyrus post L 68
Parietal lobule L 685 −3.96 0.00006 <0.001 −38 −58 54 88
Supramarginal gyrus L 38
Angular gyrus L 425
Occipital pole L 134
Middle temp gyrus post R 53 −3.89 0.00007 0.062 60 −46 2 53
Precentral gyrus L 95 −3.57 0.00024 0.016 −40 2 52 32
Post dorsolateral
frontal cortex L
63
Post dorsolateral
frontal cortex L
97 −3.46 0.00035 0.015 −36 18 50 97
Region names derive from the intersection of regions identified by SPM using the Tziortzi atlas [29]. t values are calculated from a linear contrast for
every voxel, the peak t value being the voxel with highest t value in the cluster
p(peak voxel) is the p value that corresponds to the peak t value within each cluster, calculated with 154 degrees of freedom. p(uncorrected cluster) is the
p value calculated using SPM2, reflecting the significance of cluster size of regions that meet the criteria for significance (i.e. the likelihood that a cluster
of that size being found based on Gaussian field theory and functional image smoothness)
a Regions that did not meet the criteria for significance
Ant, anterior; Inf, inferior; L left; Post, posterior; R right; Sup, superior; Temp, temporal
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be reacting to the hypoglycaemic stress responses. Activation
of orbital cortex is likewise consistent with non-diabetic re-
sponses to comparable hypoglycaemia [13, 14, 18] but not
previously observed in type 1 diabetes [19]. The orbital cortex
encodes stimulus value or salience [32], and the lateral orbital
cortex forms a ‘salience’ network with the ACC [33].
Activation of the DLF cortex in response to hypoglycaemia
has not previously been described [12–14, 18, 19]. It has a role
in working memory—the short-term recall and processing of
information necessary for complex task performance, includ-
ing learning and reasoning [34]—and is involved in inhibitory
control [35, 36]. Changing activity during hypoglycaemia is
consistent with clinically observed changes in cognition and
behavioural disinhibition during hypoglycaemia, and recall
after it. The report of activation of the precuneus and angular
gyrus during established hypoglycaemia and recovery is also
novel [12–14, 19]. The precuneus is part of the ‘default mode
network’, showing reduced activity compared with the resting
state when undertaking tasks [33]; activation may reflect less-
er ability to perform tasks during hypoglycaemia. The angular
gyrus, linked to the DLF cortex [37] and showing parallel
responses, plays a role in regulating shift of attention to more
salient stimuli [38]. The amygdala encodes the predicted bio-
logical relevance of a stimulus [39]; its activation in recovery
may be a key determinant of responses to subsequent
hypoglycaemic events.
Deactivation of the inferior temporal gyri in all three
phases, of parietal regions during established hypoglycaemia
and recovery, and of parahippocampal regions during
established hypoglycaemia, described in some studies of indi-
viduals without diabetes but not previously in type 1 diabetes,
provide a neurological correlate of failure to form memory
during hypoglycaemia: temporal gyri for semantic or concep-
tual memory [40], and parahippocampal gyrus and lateral pa-
rietal cortex for episodic memory [41].
Impact of IAH
The subtle differences in hypoglycaemia responses in IAH are
potentially important. In early hypoglycaemia, deactivation
seen in parts of the central operculum, MO cortex and poste-
rior and lateral DLF cortex in HAwas replaced by activation.
Operculum activation changes in response to food cues, mod-
ulated by feeding state and degree of liking the food [32]:
differences between IAH and HA may relate to differences
in the drive to eat to treat. These were paralleled by different
responses in the MO cortex, encoding stimulus value and
salience [32], in early and established hypoglycaemia; this
may underlie differences in perceived importance of
hypoglycaemia, including lack of aversion. Lack of activation
of the GP, with its role in memory of unpleasant experiences
or aversion [42], is also consistent with not finding
hypoglycaemia unpleasant. These are key findings, as IAH
is clinically associated with reduced motivation to avoid
hypoglycaemia [21, 22], with reduced incentive to treat
hypoglycaemia as important [43].
Parts of the dorsal and posterior DLF cortex responded
from early hypoglycaemia through to recovery with activation
responses in IAH compared with deactivation in HA.
Hypoglycaemia is associatedwith impaired inhibitory control;
perhaps the deactivation in HA represents conscious attempts
to maintain inhibitory control of behaviour during
hypoglycaemia.
The ACC is involved in decision-making and conflict res-
olution between options, and is key in monitoring perfor-
mance, evaluating actions and detecting events that require
behavioural modification and re-evaluation [44]. Lack of
ACC activation only in IAH fits with views of IAH as a
habituation response. A similar lack of activation in IAH in
the somatosensory post-central (somatosensory) and pre-
central (motor) gyri, persisting in recovery, may reflect re-
duced somatic sensations (e.g. warmth, shakiness) and motor
responses (e.g. tremor) experienced by the IAH group in
hypoglycaemia.
Minimal responses in IAH, vs deactivation in HA, in the left
posterior middle temporal gyrus during established
hypoglycaemia, and the bilateral posterior middle and left infe-
rior temporal gyri in recovery, are also consistent with different
memory formation during hypoglycaemia and recovery [40,
41]. The same is true of differences in the left parietal lobule/
angular gyrus in established hypoglycaemia, with activation in
IAH but minimal response in HA, and in recovery in the left
angular gyrus and supramarginal gyrus, with activation in IAH
and deactivation in HA. The lateral parietal cortex shows func-
tional connectivity with the hippocampal formation and is as-
sociated with recollection of experiences [41, 45].
In recovery, in addition to persisting differential responses
in somatosensory and memory networks, we found activation
in IAH and deactivation in HA in part of the medial frontal
cortex; this was in a cluster corresponding to regions of the
dorsal-medial prefrontal cortex identified as having a role in
self-referential mental activity, such as making judgements
about unpleasantness/pleasantness [46]. It may also have a
role in episodic or experiential memory [41]. This may pro-
vide a correlate for individuals with type 1 diabetes with IAH
and HA forming differently valenced memories of the experi-
ence of hypoglycaemia. However, the medial frontal cortex,
along with the lateral parietal regions discussed above, is also
a component of the default mode network [33], and these
differences may represent hypoglycaemia being a different
‘task’ for the brain in IAH than HA.
Our participants were matched well for age, diabetes duration
and diabetes control but imperfectly for BMI.Obesity alters brain
responses to food and food cues, including the responses of some
frontal regions described as different in their response to
hypoglycaemia here [47]. However, none of our participants
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was obese, so it is unlikely our observed differences in response
to hypoglycaemia were related to this. The recruitment of only
men facilitates research involving radio-isotopes and importantly
reduces variability of responses due to sex differences in
counterregulation [48]. The clinical picture of IAH is not sex-
specific so our data interpretation probably also applies to wom-
en; however, adaptation to antecedent hypoglycaemia may vary
by sex, at least in individuals without diabetes [49], and studies in
women would be of interest. Right-handedness was chosen as
many brain functions are lateralised.
The strengths of our study include pre-study determination
of awareness status on clinical grounds, so individuals defined
as having IAH were representative of those with clinically
problematic hypoglycaemia. In addition, the analysis did not
require a preconception of brain regions that might respond
differently to hypoglycaemia by awareness status. Although
less powerful than a region of interest analysis, in which data
are compared between groups only in prespecified brain re-
gions, this enabled us to identify areas not traditionally asso-
ciated with stress responses. That differences between the two
groups (the effect of awareness status on rCBF responses)
were identified at lower thresholds than those used to find
differences within groups (the effect of hypoglycaemia) is
statistically explicable: within-group comparison is always
more powerful than between-group comparison, where differ-
ences between participants come into play. It is also biologi-
cally plausible as hypoglycaemia is a large stress stimulus
whereas differences between HA and IAH are probably an
order of magnitude less. It is, however, possible that other
brain regions responding differently were missed.
Conclusion
In conclusion, we used [15O]water PET to describe the evolution
of the brain’s responses to hypoglycaemia over time in men with
type 1 diabetes and found differences related to HA status. These
differences provide a mechanism explaining the resilience of
IAH as a clinical entity highly resistant to treatment strategies
that are usually capable of restoring awareness through
hypoglycaemia avoidance. The neuroimaging differences are
compatible with a different behavioural response, with regard
to the drive to eat, different emotional salience of the experience
and differences in its recall; all may contribute in IAH to the
reduced drive to treat hypoglycaemia in timely fashion and avoid
future episodes. It remains to be determined whether these IAH-
specific central responses are induced by hypoglycaemia expo-
sure or are an inherent way of responding to stress that results in a
proportion of people susceptible to persistent IAH. If the latter, it
may be possible to detect high risk for IAH and recurrent severe
hypoglycaemia through cognitive or neuroimaging studies be-
fore the syndrome has fully developed. Meanwhile, the differen-
tial responses described are likely to correlate with cognitions
and behaviours unhelpful to future hypoglycaemia avoidance;
further research is required into how best to address these in
clinical practice.
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